Apple Halts Sales of Apple Watch Series 9 and Ultra 2 in the US Ahead of Pending Patent Ban

Apple has made the decision to stop selling the Apple Watch Series 9 and Ultra 2 in the US through its online store just days before a ban related to a patent dispute is set to take effect. In addition to this, Apple will also no longer be able to repair watch models that are out of warranty, which could potentially cause headaches for consumers who rely on Apple’s repair services.

Background on the sales ban

This sales ban was imposed by the US International Trade Commission (ITC) after it ruled that Apple had violated two health technology patents related to blood oxygen sensing. These patents are held by Masimo, a company based in Irvine, California. The ITC’s ruling highlights the significance of these patents in relation to Apple’s technology and the potential infringements.

Apple’s response to the ban

In response to the ban, Apple has posted a message on its website stating that it no longer sells Apple Watch units in the United States equipped with the ability to measure blood oxygen. This move signals Apple’s compliance with the ITC’s ruling and its efforts to avoid further legal complications.

Impact on watch repairs

Not only does the ban affect sales, but it also impacts Apple’s ability to repair out-of-warranty watch models. Apple will no longer replace these models going back to the Apple Watch Series 6. This decision has a wide-reaching impact, affecting most new Apple Watches sold since 2020, including Series 6, 7, 8, Ultra, and the current Series 9 and Ultra 2. Consumers who rely on Apple’s repair services may face difficulties in getting their out-of-warranty watches fixed.

Limitations on customer options

In addition to the restrictions on repairs, customers will also face limitations on their options regarding watch exchanges. After December 25, when the ban comes into effect, Apple will not allow customers to exchange watches purchased before the ban for different colors or sizes during the typical return period. This restriction may frustrate customers who wish to switch their watches or match them with their personal preferences.

Communication restrictions for employees

To comply with the legal order, Apple has informed its employees that they are prohibited from informing customers that the Apple Watch is still available for purchase at third-party retailers like Best Buy and Target. This restriction on communication aims to avoid further legal complications and ensure Apple’s compliance with the ban.

Duration and Potential Resolutions

The ban on the sale of Apple Watches equipped with blood oxygen measurement capabilities will remain in effect until Apple can reach a licensing agreement with Masimo, receive a federal reprieve, or successfully resolve the patent dispute. The duration of this ban is uncertain, and it will depend on the progress of negotiations or any legal actions taken by Apple.

Apple’s decision to halt the sales of the Apple Watch Series 9 and Ultra 2, as well as the limitation on out-of-warranty repairs, is a direct response to an upcoming ban resulting from patent infringements identified by the US International Trade Commission. Consumers who have purchased watches before the ban comes into effect and still have warranty coverage will not be affected, but others will face challenges in getting their watches repaired or exchanged. It is important for customers to be aware of these limitations and potential impacts on their Apple Watch purchases and repairs. Apple’s compliance with the ban demonstrates its commitment to resolving the patent dispute and finding a resolution with Masimo in the near future.

Explore more

Agile Robots and Google DeepMind Partner for AI Automation

The sight of a robotic arm fluidly adjusting its grip to accommodate a fragile, oddly shaped component marks the end of an age defined by rigid, pre-programmed industrial machinery. While traditional automation relied on thousands of lines of static code to perform a single repetitive motion, a new alliance between Agile Robots and Google DeepMind is introducing a cognitive layer

The Rise of Careerfishing and Professional Deception in Hiring

The digital age has ushered in a sophisticated era of professional masquerading where jobseekers utilize carefully curated fictions to bypass traditional recruitment filters and secure roles for which they lack genuine qualifications. This phenomenon, increasingly known as careerfishing, mirrors the deceptive nature of online dating scams but targets the high-stakes world of corporate talent acquisition. It represents a deliberate, calculated

How Is HealthTech Redefining the Future of Talent Acquisition?

A single line of inefficient code in a modern clinical algorithm no longer just causes a screen to freeze; it can delay a life-saving diagnosis or disrupt the delicate flow of a decentralized clinical trial. In the high-stakes world of healthcare technology, the traditional boundaries of recruitment are dissolving as the industry shifts from a focus on static technical skills

AI Literacy Becomes the Fastest Growing Skill in HR

The traditional image of a human resources professional buried under a mountain of paper resumes and manual spreadsheets has vanished, replaced by a new breed of data-fluent strategist. Recent LinkedIn data reveals that AI-related competencies are now the fastest-growing additions to HR profiles across the globe, signaling a radical departure from the administrative roots of the profession. This surge in

Custom CRM Transforms Pharmaceutical Supply Chain Operations

A single delayed shipment of temperature-sensitive medicine can ripple through a healthcare network, yet many distributors still rely on the fragile logic of disconnected spreadsheets to manage their complex global inventories. In the high-stakes world of pharmaceutical logistics, the movement of life-saving goods requires more than just a warehouse; it demands a digital nervous system capable of tracking every pill